timothy sykes logo
LASE Stock Surges As Defense Contracts Hype Builds Thumbnail

LASE Stock Surges As Defense Contracts Hype Builds

BRYCE TUOHEYUPDATED JUN. 3, 2026, 9:19 AM ET
Reviewed by Tim Sykesand Fact-checked by Matt Monaco

Laser Photonics Corporation stocks have been trading up by 41.74 percent, buoyed by strong investor optimism from the latest news

Candlestick Chart

Live Update At 09:18:43 EDT: On Wednesday, June 03, 2026 Laser Photonics Corporation stock [NASDAQ: LASE] is trending up by 41.74%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

LASE has been trading like a classic low-priced momentum name. For most of May 2026, Laser Photonics stock chopped around the $0.82–$0.93 range, with tight closes and low daily ranges. Then on 2026/06/02, LASE exploded from an open near $1.21 to a close around $2.42, with a day range from roughly $1.08 to $2.47. That is the kind of range that brings short-term traders off the sidelines.

Intraday, the 5-minute tape shows LASE holding the bulk of its premarket spike above $3.00, with repeated pushes into the $3.40–$3.70 zone. That tells traders two key things: dip buyers are active, and shorts are not fully in control yet. Volatility is elevated, which is attractive for day trading but demands strict risk management.

Fundamentals show a tiny, high-risk company. Laser Photonics generated about $8.34M in revenue, but profit margins are deeply negative, with return on equity sharply in the red and current and quick ratios at 0.3 and 0.1. LASE is burning cash, with roughly -$4.96M in operating cash flow and free cash flow near -$4.97M in the last reported quarter. For traders, that means the story is momentum and catalyst-driven, not a value play.

Why Traders Are Watching LASE Right Now

LASE is moving because story and tape finally lined up. The big catalyst is the Laser Shield Anti-Drone (LSAD) system. Laser Photonics and its affiliate Fonon Technologies got LSAD selected by the U.S. Department of War under the MEIA Vulcan Call for Solutions as a top Counter C5ISR-T candidate. That selection came with a one-on-one technical exchange with government engineers. For traders, that reads like “early access” to a possible prototyping and defense-transition path.

This is not just a slide deck concept. Earlier, Laser Photonics and Fonon pushed LSAD from initial testing into system prototyping and extended-range trials. On top of that, the company plans to showcase the prototype LSAD system to Defense Directorate Program Executive Offices at SOF Week, a key special operations event. LASE is now a live participant in the defense counter-drone conversation, not a bystander.

At the same time, Laser Photonics is building breadth. Its DefenseTech Missile Laser Rust Inhibitor was successfully piloted and validated at a U.S. Army depot, where it reduced maintenance cycle times, cut environmental impact, and streamlined missile maintenance workflows. Traders see that as proof the tech solves real problems, with potential for replication at other depots.

Beyond defense, LASE’s CMS Laser unit secured a $250K custom drilling order from Johnson & Johnson to validate a medical device application. The dollar figure is small, but the name is big. It signals Laser Photonics can land work in regulated, sticky medical manufacturing.

All this sits on top of a flurry of DefenseTech product launches — the MRLS Portable Finishing Laser 1020, MRLS Marking Laser 5010, and DefenseTech Blaster Cabinet 4020 — aimed at field and depot maintenance. LASE is positioning itself as a portfolio play on laser-based military maintenance and logistics, not a single-project flyer.

More Breaking News

Conclusion

For active traders, LASE right now is a blend of high volatility, high risk, and real headline catalysts. Laser Photonics is still a small, cash-burning company with negative earnings and weak liquidity metrics. The balance sheet shows limited cash and significant liabilities, so dilution and financing risk remain part of the story. That is standard in this corner of the market.

But the recent price action in LASE is not random. The Department of War recognition for LSAD, the move into prototyping and extended-range trials, and exposure at SOF Week all raise the ceiling on potential defense-related news flow. The U.S. Army depot validation of Laser Photonics’ rust inhibitor system and the Johnson & Johnson order for CMS Laser add industrial and medical credibility that many microcaps never reach.

Governance is also getting attention. The appointment of Roman Franklin as CFO and principal financial officer suggests Laser Photonics is trying to professionalize its reporting and capital markets playbook just as its DefenseTech offerings gain traction. For traders, that reduces some execution risk but does not erase it.

The key for anyone trading LASE is to treat it as a tactical opportunity around catalysts, not a “set and forget” hold. As Tim Sykes often says, “The pattern is your edge, not the promise.” As millionaire penny stock trader and teacher Tim Sykes says, “Be patient, don’t force trades, and let the perfect setups come to you.” Laser Photonics has a powerful story in defense lasers and industrial systems, but the chart and the news flow — not the hype — should guide every trade. This analysis is for educational and research purposes only and is not advice.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:



How much has this post helped you?


Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”